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The TCR Triggering Puzzle Minireview
in signaling through either induced proximity of associ-P. Anton van der Merwe1
ated signaling molecules or, as suggested more recentlySir William Dunn School of Pathology
(Harder, 2001), the partitioning of aggregated TCR/CD3University of Oxford
complexes into lipid rafts that are themselves enrichedOxford OX1 3RE
in signaling molecules. Such models require the simulta-United Kingdom
neous engagement of at least two adjacent TCRs by
pep-MHC and so fail to account for the fact that TCR
triggering can occur at, and indeed is most efficient at
T cell antigen recognition requires the binding of the T (Lanzavecchia et al., 1999), very low densities of pep-
cell antigen receptor (TCR) to a complex between an MHC. A possible solution to this difficulty was provided
antigen (usually peptide) and an MHC molecule (pep- by two studies using soluble TCR and pep-MHC, which
MHC). This leads to a series of signaling events collec- suggested that, following pep-MHC binding, TCR/pep-
tively referred to as TCR triggering, which is mediated MHC complexes oligomerize (Reich et al., 1997; Alam
by a group of TCR-associated transmembrane signaling et al., 1999). The mechanism proposed was that, upon
molecules, the CD3 complex. Although it has been inten- binding, the TCR or TCR/pep-MHC complex acquires
sively studied, we still do not have satisfactory answers the ability to bind directly to another TCR or TCR/pep-
to two fundamental and related questions concerning MHC complex. However, the structural diversity of TCR/
TCR triggering. First, by what mechanism does TCR pep-MHC complexes noted above raises doubts as to
binding to pep-MHC result in triggering? Second, what whether binding-induced self-association can be a gen-
binding property governs whether a particular TCR/pep- eral feature of TCR/pep-MHC interactions. Furthermore,
MHC interaction will lead to triggering? I discuss both individual TCR/pep-MHC complexes are quite heavily
of these questions here with special reference to two glycosylated and surrounded by CD3 and coreceptor
important recent papers (Baker and Wiley, 2001; Kal- glycoproteins (Rudd et al., 1999), which would seem to
ergis et al., 2001), the former being published in this preclude direct physical association of two or more
issue of Immunity. TCR/pep-MHC complexes. These doubts are supported
Many ideas concerning TCR triggering have been influ- by a study reported in this issue that looked for evidence
enced by insights gleaned from other receptor systems, of binding-induced self-association in two soluble TCR/
particularly receptors that, like the TCR, signal by stimu- pep-MHC systems (Baker and Wiley, 2001). Using sev-
lating tyrosine phosphorylation. However, the TCR/pep- eral sensitive techniques, including those used by Reich
tide-MHC interaction has unique features that should et al. (1997) and Alam et al. (1999), they convincingly
be borne in mind when considering possible answers rule out self-association in these systems. Taken to-
to the questions posed above. First, the pep-MHC bind- gether with other studies (e.g., Willcox et al., 1999) that
ing site on a TCR is generated in a quasi-random man- find no evidence of the complex binding kinetics that
ner, and there is enormous diversity in the fine structure should be observed with self-association, this suggests
of interacting TCR and pep-MHC binding surfaces. Sec- that binding-induced self-association is not a general
ond, following crystallographic analysis of only a handful feature of TCR/pep-MHC interactions and is therefore
of pep-MHC complexes it is already clear that the orien- unlikely to be the mechanism of TCR triggering.
tation in which different TCRs engage pep-MHCs, al- Conformational change models typically propose
though constrained to a certain extent, is quite variable that, upon binding to pep-MHC, a TCR undergoes a
(Garcia et al., 1999; Hennecke and Wiley, 2001). For conformational change that is somehow transmitted to
example, the angle of engagement measured around the associated CD3 signaling machinery. The difficulty
the long axis of the TCR/pep-MHC complexes studied with these models is that they require, implausibly, that
there is a conformational change in the TCR coupled tothus far differs by up to 35 (Hennecke and Wiley, 2001).
binding that is conserved in all TCRs in the face ofConsequently, the structure of TCR/pep-MHC com-
enormous and semirandom variability in the TCR/pep-plexes is also likely to vary. Finally, T cells are required
MHC binding interface. The fact that a number of recentto, and are able to, recognize exceptionally low levels
structural studies have failed to reveal any evidence forof specific pep-MHC on cells (see Kimachi et al., 1997,
conformational changes in the TCR other than adjust-and references therein); indeed, a single pep-MHC com-
ments at the binding interface would seem to rule outplex on a target cell may be sufficient.
such models (Garcia et al., 1999; Hennecke and Wiley,Triggering Models
2001). A more plausible conformational change modelThe models that have been proposed for TCR triggering
has been proposed recently that is compatible with thecan be divided into three groups depending on whether
available structural data (Ding et al., 1999). Accordingthey invoke, as mechanisms of signal transduction,
to this dimer conformational change model, two TCRsbinding-induced multimerization, binding-induced con-
are present as a preformed dimer (i.e., two TCRs),formational change, or neither (Figure 1). Multimeriza-
and simultaneous binding of each TCR to specific pep-tion models propose that ligand engagement brings to-
MHC alters the relative orientation of the two TCRs.gether two or more TCR/CD3 complexes, which results
Interest in the latter model has been stimulated by evi-
dence for the existence of preformed TCR dimers on
the T cell surface (Fernandez-Miguel et al., 1999). While1Correspondence: anton.vandermerwe@path.ox.ac.uk
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Figure 1. TCR Triggering Models
The key early event in all the illustrated models is tyrosine phosphorylation of CD3 chains. In the kinetic-segregation model, it is proposed
that tyrosine phosphorylation of unengaged TCR/CD3 in the close-contact regions is transient because unligated TCR/CD3 will soon diffuse
out of the close-contact region and be exposed to tyrosine phosphatases. In contrast, engaged TCR/CD3 is “held” within this region, enabling
subsequent triggering steps to proceed.
the dimer adjustment model, like multimerization mod- zone is accompanied by exclusion or segregation from
the zone of membrane tyrosine phosphatases, many ofels, requires the simultaneous engagement of two adja-
cent TCRs, the presence of preformed TCR dimers which, like CD45 and CD148, have large ectodomains
that could drive exclusion. It is important to stress thatshould significantly increase the likelihood of this event.
The evidence and arguments outlined above have in- the segregation proposed here is on a much smaller
scale than the large-scale segregation of cell-surfacecreased interest in models of TCR triggering that do not
invoke conformational change or multimerization (Figure molecules characteristic of the immunological synapse
that forms between an activated T cell and APCs or1). One such model postulates that triggering results
from the heterodimerization of the TCR with the CD8 or target cells (Monks et al., 1998; Grakoui et al., 1999;
Stinchcombe et al., 2001). The latter follows and de-CD4 coreceptors following binding to the same pep-
MHC complex, thereby inducing proximity between the pends upon TCR triggering and so cannot be the mecha-
nism of TCR triggering (van der Merwe et al., 2000). ItTCR/CD3 complex and coreceptor-associated signaling
molecules. Support for such a model was provided by has been proposed instead that large-scale segregation
is required for, or the result of a process required for,the observation that monovalent soluble pep-MHC can
trigger T cells provided that they express CD8 (Delon polarized secretion by T cells toward antigen-presenting
or target cells (Davis and van der Merwe, 2001).et al., 1998). However, coreceptor heterodimerization
cannot be a general mechanism since TCR triggering Binding Properties
What feature of a TCR/pep-MHC interaction determinescan occur in cells entirely lacking coreceptors. The raft
association model (not shown in Figure 1) postulates whether pep-MHC binding will result in TCR triggering?
The notion that the nature of the response is determinedthat TCR engagement leads to association of that TCR/
CD3 complex with lipid rafts (Lanzavecchia et al., 1999). by the particular structural change induced in a TCR
can probably be ruled out, for two reasons. First, theHowever, no convincing mechanism has been proposed
to explain how engagement of a single TCR/CD3 leads highly variable structure of TCR/pep-MHC interfaces
makes it implausible that the same conformationalto raft association. The kinetic-segregation model (Davis
and van der Merwe, 1996; van der Merwe et al., 2000) changes are induced in all TCRs in response to ligand
binding. Second, there is no evidence of structuralproposes that pep-MHC binding induces triggering by
tethering the TCR/CD3 complex within a zone of close changes in TCR/pep-MHC complexes that correlate
with the functional outcome of binding (Garcia et al.,membrane contact in which tyrosine phosphorylation is
favored. While the TCR/CD3 complex is held in this zone, 1999; Hennecke and Wiley, 2001). Particularly convinc-
ing are the demonstrations that the structure of a giventhe sequence of phosphorylation and phosphorylation-
dependent steps required for TCR triggering can pro- TCR is essentially the same whether bound to agonist,
superagonist, or antagonist pep-MHC (Ding et al., 1999;ceed. The model proposes that tyrosine phosphoryla-
tion is favored because the formation of a close-contact Degano et al., 2000).
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It would seem more plausible that the TCR response or target cell. Crucially, the half-life of an interaction
is determined by a binding property related to binding decreases when subjected to mechanical stress, but
strength, such as affinity or half-life. It is unlikely for two the extent to which it decreases will vary between inter-
reasons that the affinity per se is the key property. First, actions. Where studied, the binding property that corre-
differences in affinity can only be detected by the T cell lates best with the mechanical strength of a bond was
as a difference in the number of engaged TCRs, which the activation enthalpy (Leckband, 2000). It may be sig-
fails to account for situations in which only a few pep- nificant therefore that TCR/pep-MHC interactions have
MHC complexes are sufficient to trigger a T cell. Second, a remarkably high activation enthalpy (Boniface et al.,
it is difficult to envisage how the TCR could discriminate 1999; Willcox et al., 1999), suggesting considerable me-
between ligands with small differences in affinity, as is chanical strength. This is consistent with the observa-
the case. More attractive is the notion that the T cell tion that T cells can extract and internalize engaged
response is dependent on the half-life of the TCR/pep- pep-MHC from target cells (Huang et al., 1999) and tend
MHC interaction. By coupling a dependence on half- to leave behind TCRs when forcibly detached from pla-
life with a requirement for several consecutive signaling nar bilayers presenting pep-MHC to which they bind
steps for TCR triggering, the TCR can discriminate very (Dustin et al., 1996). These observations suggest that
effectively between pep-MHCs that differ only slightly TCR/pep-MHC half-lives at the cell:cell interface may
in their TCR binding half-lives (McKeithan, 1995). not always correlate with half-lives measures in solution,
A number of studies have measured the affinity and and raise the question as to whether the mechanical
kinetics of interactions between soluble forms of TCR strength of a TCR/pep-MHC interaction, by determining
and pep-MHC and attempted to correlate these proper- the half-life under mechanical stress, is an important
ties with the functional outcome of the interaction. While determinant of TCR triggering.
there is a crude correlation between binding strength Conclusions
as measured by affinity or half-life and T cell response, Despite extensive efforts, the mechanism of TCR trig-
this correlation tends to break down when TCR/pep- gering remains poorly understood, and there are a num-
MHC interactions with smaller (2- to 5-fold) differences in ber of competing models. There are major difficulties
affinity or half-life are compared. One possible explanation with more traditional models such as those postulating
for this is suggested by the recent study by Kalergis et binding-induced conformational change of the TCR or
al. (2001). They measured the dissociation half-life of pep- binding induced-multimerization. Newer models, such
MHC class I tetramers from T cells and correlated these as the dimer conformational change, raft-association,
with functional responses. In the two systems studied, and kinetic-segregation models, have been proposed
they found that TCR/pep-MHC interactions with the lon- that are compatible with the available data, but they
gest half-lives did not give the best functional response. have yet to be rigorously tested.
Importantly, a TCR mutation that reduced the half-lives There is more consensus on which property of TCR/
of “long half-life” pep-MHCs actually enhanced TCR pep-MHC interactions determines the outcome of bind-
triggering. Thus, there appears to be an optimal TCR/ ing. Structural consideration and data have ruled out
pep-MHC half-life or “dwell time” with longer and shorter ligand-specific conformational changes as a determi-
half-lives correlating with poorer responses. This was nant. The available data are broadly consistent with the
predicted by, and provides support for, the serial trig- hypothesis that there is an optimal half-life or dwell-
gering model (Lanzavecchia et al., 1999), which postu- time for TCR/pep-MHC interactions. Some data are not
lates that a certain threshold number of TCRs needs to consistent with this, possibly because the TCR/pep-
be engaged for T cell activation, and that each pep- MHC half-life is different under physiological conditions
MHC can serially engage multiple TCRs. It follows that in which the interaction is subjected to mechanical
pep-MHCs that engage TCRs with a half-life longer than stress. Measurements of the mechanical properties of
that required for triggering will be less effective agonists
TCR/pep-MHC interactions and direct measurement of
because they will trigger fewer TCRs in a given time
the kinetics of membrane-tethered TCR/pep-MHC inter-
period.
actions are needed to clarify this question.There remain, however, data that are not explained
by the optimal dwell time/serial triggering model. For Selected Reading
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